Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine versus doxycycline for rosacea
ChiCTR-IPR-17012224Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydroxychloroquine and doxycycline in rosacea, sponsored by Xiangya Hospital, Central South University. Started Mar 2016; status: recruiting.
02
Drugs
hydroxychloroquinedoxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR-IPR-17012224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012224.